Ground-breaking Cancer Diagnostic Technology Receives Phase 2 SBIR Grant
Grant will further validate Cernostics’ diagnostic technology for predicting risk of future progression to esophageal cancer in patients with Barrett’s Esophagus PITTSBURGH, PA. – The National Institutes of Health have awarded C...
Read more
